TABLE 1.
Investigation | Finding |
---|---|
Blood chemical investigations | |
CK, CK-MB | Myocardial cell damage |
Brain natriuretic peptide | Heart failure |
Electrocardiogram | Rhythm abnormalities, myocardial damage |
Ambulatory electrocardiogram | Vegetative impairment |
Echocardiography | hCMP, dCMP, ventricular dysfunction |
Backscatter analysis | Myocardial fibrosis, arrhythmias |
Thallium scintigraphy | Reduced myocardial perfusion |
Technetium ventriculography | Systolic and diastolic dysfunction |
MIBG-SPECT | Sympathetic hyperactivity |
Cardiac magnetic resonance imaging | hCMP, dCMP, LVHT, fibrosis |
Magnetic resonance spectroscopy | Reduced dystrophin expression |
Endomyocardial biopsy | Fibrosis, LVHT, atrophic myocardiocytes |
CK Creatine kinase; dCMP Dilative cardiomyopathy; hCMP Hypertrophic cardiomyopathy; LVHT Left ventricular hypertrabeculation; MIBG Metaiodobenzylguanidine; SPECT Single photon emission computed tomography